Your Messages Inbox
Your Article Summary
See Latest ArticlesTeva And Ortho-McNeil-Janssen Settle Ortho Tri-Cyclen Lo Litigation
Teva Pharmaceutical Industries, 07/27/09
Teva Pharmaceutical Industries Ltd. announced that it has entered into a definitive agreement with Ortho–McNeil–Janssen to settle the patent infringement lawsuit in the U.S. District Court for the District of New Jersey related to Teva's generic version of the oral contraceptive, Ortho Tri–Cyclen Lo. Under the terms of the settlement, Teva will obtain a release for past sales of its generic product, in exchange for an undisclosed royalty payment. Teva also will obtain a license to re–enter the market on December 2015, or earlier in certain circumstances. The settlement will not become effective until the court enters a proposed consent judgment upholding the validity and enforceability of Ortho's patent.
Today in M&A/Partnerships...keeping you current
Receive free subspecialty "5-minute updates" via email
Inno Biologics and CEVEC Sign License Agreement for Human CAP Technology
b3c newswire, 12/09/09
Federal Advisory Committees to Meet
HealthDataManagement, 12/09/09
Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR
Mylan, 12/09/09
Article Search
Sponsor